Micotef (Miconazole Nitrate)

• Micotef, an imidazole antifungal, acts on Candida species that cause vaginal yeast infections.
• Vulvovaginal candidiasis: reduces fungal load and relieves symptoms such as itching, burning, and abnormal discharge.
• Recurrent vulvovaginal candidiasis: helps prevent repeat episodes when used as directed by a healthcare professional.
• Vaginal yeast infection: eradicates Candida overgrowth to restore normal vaginal flora.

• Miconazole nitrate inhibits the fungal cytochrome P450 enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. By blocking ergosterol production, the drug disrupts cell membrane integrity, leading to increased permeability and ultimately fungal cell death. This inhibition is concentration‑dependent and results in rapid reduction of viable Candida organisms within the vaginal mucosa.

Miconazole nitrate may cause local or systemic adverse reactions, most of which are mild and transient.

Common Side Effects

• Local irritation: mild burning or stinging at the application site.
• Vaginal discharge: increased or altered discharge during treatment.
• Itching: transient pruritus of the vulvar area.
• Unpleasant odor: temporary change in vaginal odor.

Serious or Rare Side Effects

• Allergic reaction: rash, swelling, or hives indicating hypersensitivity.
• Severe skin reaction: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Liver enzyme elevation: signs of hepatic dysfunction such as jaundice.
• Vaginal ulceration: painful sores requiring medical evaluation.

• Before using Micotef, consider the following safety measures and warnings.
• Pregnancy: consult a healthcare professional before use, as safety data are limited.
• Breastfeeding: use with caution; discuss potential risks with a physician.
• Allergy: avoid if known hypersensitivity to miconazole or other imidazoles.
• Hepatic impairment: use only under medical supervision in patients with severe liver disease.
• Prolonged use: do not exceed recommended duration without physician guidance.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Miconazole nitrate can affect the activity of other medicines; interactions are classified by their clinical significance.

Major Interactions (Avoid)

• Systemic azole antifungals (e.g., ketoconazole, fluconazole): increased risk of toxicity due to additive inhibition of CYP450 enzymes.
• Warfarin: enhanced anticoagulant effect, may require monitoring of INR.
• Oral contraceptives: reduced efficacy, consider alternative non‑hormonal contraception.
• Rifampin: strong CYP450 inducer that may lower miconazole levels, decreasing effectiveness.

Moderate Interactions (Monitor Closely)

• Topical corticosteroids: may increase local irritation when used together.
• Antihistamines: possible additive effect on sedation if systemic absorption occurs.
• Other vaginal products (e.g., douches, spermicides): may interfere with drug absorption.